In the current study, we established the basis for which the flavone, chalcone, and chromone synthetic structures might work as a treatment option for PCa patients with depression by reversibly inhibiting MAO-A and reducing oxidative stress. This evidence concerns the gene MAOA and posterior cortical atrophy.